Advertisement

23 Speekselovervloed: sialorroe en hypersalivatie

Chapter
  • 895 Downloads

Samenvatting

Om hypersalivatie te reduceren kunnen de volgende aanbevelingen worden gedaan:

  • aanleren van slikreflexen met behulp van logopedie;

  • aanleren van een goede lichaamshouding met medewerking van fysiotherapie of houdingstherapieën;

  • cognitieve therapie;

  • regelmatig leren slikken door te zuigen op zuigtabletten (Bentasil® en dergelijke);

  • reduceren van de speekselsecretie door het nuttigen van suikervrije, bittere drank, zoals het regelmatig nippen van kleine hoeveelheden koude zwarte koffie of thee;

  • zuivelproducten geven vaak een slijmerige nawerking;

  • een lage dosering van anticholinergica zoals scopolamine (Scopoderm®), benzatropine en glycopyrrolaat remmen de speekselsecretie;

  • toepassen van gerichte acupunctuur;

  • lokaal appliceren van botulinetoxine A; dit toxine remt gedurende een aantal maanden de speekselafgifte en kan daarna herhaald worden;

  • radiotherapie in lage dosis op de speekselklieren; dit leidt tot reductie van de speekselafgifte.

Literatuur

  1. Acosta-Armas A.J. Two cases of parotid gland swelling in patients taking clozapine. Hosp. Med. 62, (2001)704–705.PubMedGoogle Scholar
  2. Andersen P.M., H. Grönberg, L. Franzen en U. Funegård. External radiation of the parotid glands significantly reduces drooling in patients with motor neurone disease with bulbar paresis. J. Neurol. Sci. 191, (2001)111–114.PubMedCrossRefGoogle Scholar
  3. Arneberg P., K. Storhaug en L. Sandvik. Effect of a slow release transcutaneous scopolamine application on salivary flow, pH, buffering action, and salivary levels of Streptococcus mutans and Lactobacilli. Scand. J. Dent. Res. 97, (1989)408–414.PubMedGoogle Scholar
  4. Bai Y.-M., C.-C. Lin, J.Y. Chen en W.C. Liu. Therapeutic effect of pirenzepine for clozapine-induced hypersalivation: a randomized, double-blind, placebo-controlled, cross-over study. J. Clin. Psychopharm. 21, (2001)608–611.CrossRefGoogle Scholar
  5. Bakke M., N.M. Thorsen, A. Bardow, T. Dalager, C. E. Thomsen en L. Regeur. Treatment of gustatory sweating with low-dose botulinum toxin A: A case report. Acta Odontol. Scand. 64, (2006)129–133.PubMedCrossRefGoogle Scholar
  6. Banerjee K.J., C. Glasson en S.J. O’Flaherty. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy. Dev. Med. Child Neurol. 48, (2006)883–887.PubMedCrossRefGoogle Scholar
  7. Becmeur F., P. Horta-Geraud, B. Brunot, M. C. Maniere, Y. Prulhiere en P. Sauvage. Diversion of salivary flow to treat drooling in patients with cerebral palsy. J. Pediatr. Surg. 31, (1996)1629–1633.PubMedCrossRefGoogle Scholar
  8. Ben-Aryeh H., T. Jungerman, R. Szargel, E. Klein en D. Laufer. Salivary flow-rate and composition in schizophrenic patients on clozapine: subjective reports and laboratory data. Biol. Psychiatr. 39, (1996)946–949.CrossRefGoogle Scholar
  9. Benson J., K.K. Daugherty en K. Kimberly. Botulinum toxin A in the treatment of sialorrhea. Ann. Pharmacother. 41, (2007)79–85.PubMedCrossRefGoogle Scholar
  10. Blasco P.A. en J.H. Allaire. Drooling in the developmentally disabled management practices and recommendations: Review Article. Dev. Med. Child Neurol. 34, (1992)849–862.PubMedCrossRefGoogle Scholar
  11. Borg M. en F. Hirst. The role of radiation therapy in the management of sialorrhea. Int. J. Rad. Oncol. Biol. Phys. 41, (1998)1113–1119.CrossRefGoogle Scholar
  12. Burg J. van der, P. Jongerius, J. van Limbeek, K. van Hulst en J. Rotteveel. Drooling in children with cerebral palsy: a qualitative method to evaluate parental perceptions of its impact on daily life, social interaction, and self-esteem. Int. J. Rehabil. Res. 29, (2006)179–182.PubMedCrossRefGoogle Scholar
  13. Burton M.J. The surgical management of drooling. Dev. Med. Child Neurol. 33, (1991)1110–1116.PubMedCrossRefGoogle Scholar
  14. Bushara K.O., D.M. Park, J.C. Jones en H.S. Schutta. Botulinum toxin - a possible new treatment for axillary hyperhidrosis. Clin. Exp. Dermatol. 21, (1996)276–278.PubMedCrossRefGoogle Scholar
  15. Chang C.-J. en A.M.-K. Wong. Intraductal laser photocoagulation of the bilateral parotid ducts for reduction of drooling in patients with cerebral palsy. Plast. Reconstr. Surg. 107, (2001)907–913.PubMedCrossRefGoogle Scholar
  16. Chou K.L., M. Evatt, V. Hinson en K. Kompoliti. Sialorrhea in Parkinson’s disease: a review. Movement Disorders 22, (2007)2306–2313.PubMedCrossRefGoogle Scholar
  17. Collins L.M.C. en C. Dawes. The surface area of the adult human mouth and thickness of the salivary film covering the teeth and oral mucosa. J. Dent. Res. 66, (1987)1300–1302.PubMedCrossRefGoogle Scholar
  18. Crysdale W.S., C. McCann, L. Roske, M. Joseph, D. Semenuk en P. Chait. Saliva control issues in the neurologically challenged. A 30 year experience in team management. Int. J. Ped. Otolaryngol. 70, (2006)519–527.CrossRefGoogle Scholar
  19. De M., R. Adair, K. Golchin en M.J. Cinnamond. Outcomes of submandibular duct relocation.: a 15 year experience. J. Laryngol. Otol. 117, (2003)821–823.PubMedGoogle Scholar
  20. Dressler D. Pharmakologische Aspekte therapeutischer Botulinum-toxin-Präparationen. Der Nervenarzt 8, (2006)912–921.CrossRefGoogle Scholar
  21. Ellies M., E. Laskawi, G. Tormahlen en W. Golz. The effect of local injection of botulinum toxin A on the parotid gland of the rat. J. Oral Maxillofac. Surg. 58, (2000)1251–1256.PubMedCrossRefGoogle Scholar
  22. Ellies M., R. Laskawi, MS. Rohrbach-Volland en C. Arglebe. Botulinum toxin to reduce saliva flow: selected indications for ultrasound-guided toxin application into salivary glands. Laryngoscope 112, (2002)82–86.PubMedCrossRefGoogle Scholar
  23. Ellies M., S. Rohrbach-Volland, C. Arglebe, B. Wilken, R. Laskawi en F. Hanefeld. Successful management of drooling with Botulinum toxin A in neurologically disabled children. Neuropediatrics 33, (2002)327–330.PubMedCrossRefGoogle Scholar
  24. Ellies M., R. Laskawi, S. Rohrbach-Volland en C. Arglebe. Up-to-date report of Botulinum toxin therapy in patients with drooling caused by different etiologies. J. Oral Maxillofac. Surg. 61, (2003)454–457.PubMedCrossRefGoogle Scholar
  25. Ellies M., U. Gottstein, S. Rohrbach-Volland, C. Arglebe en R. Laskawi. Reduction of salivary flow with botulinum toxin: Extended report on 33 patients with drooling, salivary fistulas, and sialadenitis. Laryngoscope 114, (2004)1856–1860.PubMedCrossRefGoogle Scholar
  26. Ghezzi E.M. en J.A. Ship. Aging and secretory reserve capacity of major salivary glands. J. Dent. Res. 82, (2003)844–848.PubMedCrossRefGoogle Scholar
  27. Glaser D.A. The use of Botulinum toxins to treat hyperhidrosis and gustatory sweating syndrome. Neurotox. Res. 9, (2006)1–6.CrossRefGoogle Scholar
  28. Grant R., S. Miller, D. Simpson, P.J. Lamey en I. Bone. The effect of Chorda Tympani section on ipsilateral and contralateral salivary secretion and taste in man. J. Neurol. Neurosurg. Psych. 52, (1989)1058–1062.CrossRefGoogle Scholar
  29. Guntinas-Lichius O. Increased botulinum toxin type A dosage is more effective in patients with Frey’s syndrome. Laryngoscope 112, (2002)746–749.PubMedCrossRefGoogle Scholar
  30. Guntinas-Lichius O. en H.E. Eckel. Temporary reduction of salivation in laryngectomy patients with pharyngocutaneous fistulas by botulinum toxin A injection. Laryngoscope 112, (2002)187–189.PubMedCrossRefGoogle Scholar
  31. Harriman M., M. Morrison, J. Hay, M. Revonta, A. Eisen en B. Lentle. Use of radiotherapy for control of sialorrhea in patients with amyotrophic lateral sclerosis. J. Otolaryngol. 30, (2001)242–245.PubMedCrossRefGoogle Scholar
  32. Heine R.G., A.G. Catto-Smith en D.S. Reddihough. Effect of antireflux medication on salivary drooling in children with cerebral palsy. Dev. Med. Child Neurol. 38, (1996)1030–1036.PubMedCrossRefGoogle Scholar
  33. Hockstein N.G., D.S. Samadi, K. Gendron en S.D. Handler. Sialorrhea: A management challenge. Am. Fam. Physician 69, (2004)2628–2634.PubMedGoogle Scholar
  34. Hönig J.F. en H.A. Merten. Medikamentöse Beeinflüssung postoperativer Sialorrhoe. Münch. Med. Wschr. 134, (1992)334–335.Google Scholar
  35. Jongerius P.H., J.J. Rotteveel, F. van den Hoogen, F. Joosten, K. van Hulst en F.J.M. Gabreëls. Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy. Presentation of a case series. Eur. J. Pediatr. 160, (2001)509–512.PubMedCrossRefGoogle Scholar
  36. Jongerius P.H., F. Joosten, F.J.A. Hoogen, F.J.M. Gabreels en J.J. Rotteveel. The treatment of drooling by ultrasound-guided intraglandular injections of Botulinum toxin type A into the salivary glands. Laryngoscope 113, (2003)107–111.PubMedCrossRefGoogle Scholar
  37. Kahl K.G., J. Hagenah, S. Zapf, P. Trillenberg, C. Klein en R. Lencer. Botulinum toxin as an effective treatment of clozapine-induced hypersalivation. Psychopharmacology 173, (2004)229–230.PubMedCrossRefGoogle Scholar
  38. Kalf J.G., A.M. Smit, B.R. Bloem, M.J. Zwarts en M. Munneke. Impact of drooling in Parkinson’s disease. J. Neurol. 254, (2007)1227–1232.PubMedCrossRefGoogle Scholar
  39. Kalf J.G., A.M. Smit, B.R. Bloem, M.J. Zwarts, W.M. Mulleners en M. Munneke. Botulinum toxin A for drooling in Parkinson’s disease: A pilot study to compare submandibular to parotid gland injections. Parkinsonism Rel Dis. 13, (2007b)532–534.CrossRefGoogle Scholar
  40. Kim H., Y. Lee, D. Weiner, R. Kaye, A.M. Cahill enM. Yudkoff. Botulinum toxin A injections to salivary glands: combination with single event multilevel chemoneurolysis in 2 children with severe spastic quadriplegic cerebral palsy. Archs Phys. Med. Rehabil. 87, (2006)141–144.CrossRefGoogle Scholar
  41. Lamey P.-J., T.J. Clifford, I.A. El-Karim en C. Cooper. Personality analysis of patients complaining of sialorrhoea. J. Oral Pathol. Med. 35, (2006)307–310.PubMedCrossRefGoogle Scholar
  42. Laskawi R. en S. Rohrbach. Treatment of gustatory sweating with botulinum toxin: special aspects. ORL 63, (2001)294–297.PubMedCrossRefGoogle Scholar
  43. Lew K.M., R.T. Younis en R.H. Lazar. The current management of sialorrhea. Ear Nose Throat 70, (1998)99–105.Google Scholar
  44. Mancini F., R. Zangaglia, S. Cristina, M.G. Sommaruga, E. Martignoni, G. Nappi en C. Pacchetti. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism. Movement Disorders 18, (2003)685–688.PubMedCrossRefGoogle Scholar
  45. Meningaud J.-P., P. Pitak-Arnnop, L. Chikhani en J.-C. Bertrand. Drooling of saliva: A review of the etiology and management options. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodont. 101, (2006)48–57.CrossRefGoogle Scholar
  46. Michels L.F.E. Is bij hypersalivatie behandeling met dieet of medicijnen mogelijk? Vademecum Permanente Nascholing Huisartsen 9, (1991)14–15.Google Scholar
  47. Murray C. en N. Solish. Metallic taste: An unusual reaction to botulinum toxin A. Dermatol. Surg. 29, (2003)562–563.PubMedGoogle Scholar
  48. Odwyer T.P. en B.J. Conlon. The surgical management of drooling – A 15 year follow-up. Clin. Otolaryngol. 22, (1997)284–287.CrossRefGoogle Scholar
  49. Ondo W.G., C. Hunter en W. Moore. A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson’s disease. Neurology 62, (2004)37–40.PubMedCrossRefGoogle Scholar
  50. Panarese A., S. Ghosh, D. Hodgson, J. McEwan en P.D. Bull. Outcomes of submandibular duct reimplantation for sialorroe. Clin. Otolaryngol. 26, (2001)143–146.PubMedCrossRefGoogle Scholar
  51. Petersson G.H., S. Fure, S. Twetman en D. Bratthall. Comparing caries risk factors and risk profiles between children and elderly. Swed. Dent. J. 28, (2004)119–128.PubMedGoogle Scholar
  52. Porta M., M. Gamba, G. Bertacchi en P. Vaj. Treatment of sialorroea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders. J. Neurol. Neurosurg. Psychiatry 70, (2001)538–540.PubMedCentralPubMedCrossRefGoogle Scholar
  53. Postma A.-G., M.A.A.M. Heesters en T. van Laar. Radiotherapy to the salivary glands as treatment of sialorrhea in patients with Parkinsonism. Movement Disorders 22, (2007)2430–2435.PubMedCrossRefGoogle Scholar
  54. Praharaj S.K., M. Arora en S. Gandotra. Clozapineinduced sialorrhea: pathophysiology and management strategies. Psychopharmacology 185, (2006)265–273.PubMedCrossRefGoogle Scholar
  55. Racette B.A., L. Good, S. Sagitto en J.S. Erlmutter. Botulinum toxin B reduces sialorrhea in Parkinsonism. Movement Disorders 18, (2003)1059–1061.PubMedCrossRefGoogle Scholar
  56. Reddihough D.S. en H. Johnson. Assessment and management of saliva control problems in children and adults with neurological impairment. J. Dev. Phys. Disabil. 11, (1999)17–24.CrossRefGoogle Scholar
  57. Reichel G. Botulinum-Toxin-A-Therapie bei Sialorrhö. Akt. Neurologie 26, (1999)325–326.CrossRefGoogle Scholar
  58. Robb A.S., R.H. Lee, E.B. Cooper, J.V. Siedel en N. Nusrat. Glycopyrrolate for treatment of clozapineinduced sialorrhea in three adolescents. J. Child Adolesc. Psychopharmacol. 18, (2008)99–107.PubMedCrossRefGoogle Scholar
  59. Roh J.-L., H.S. Kim en A.-Y. Kim. The effect of acute xerostomia on vocal function. Archs Otolaryngol. Head Neck Surg.132, (2006)542–546.CrossRefGoogle Scholar
  60. Savarese R., M. Diamond, E. Elovic en S.R. Miller. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy. Am. J. Phys. Med. Rehabil. 83, (2004)304–311.PubMedCrossRefGoogle Scholar
  61. Serrano-Duenas V. Treatment of sialorroe in Parkinson’s disease patients with clonidine. Doubleblind, comparative study with placebo. Neurologica 18, (2003)2–6.Google Scholar
  62. Shirley W.P., J.S. Hill, A.L. Woolley en B.J. Wiatrak. Success and complications of four-duct ligation for sialorrhea. Int. J. Pediatr. ORL 67, (2003)1–6.Google Scholar
  63. Syeda F., F. Ahsan en D.A. Nunez. Quality of life outcome analysis in patients undergoing submandibular duct repositioning surgery for sialorrhoea. J. Laryngol. Otol. 121, (2007)555–558.PubMedCrossRefGoogle Scholar
  64. Tan E.K. Botulinum toxin treatment of sialorrhea: comparing different therapeutic preparations. Eur. J. Neurol. 13, (2006)S60–S64.CrossRefGoogle Scholar
  65. Tassinari D., B. Poggi, M. Fantini, E. Tamburini en S. Sartori. Treating sialorrhoea with transdermal scopolamine. Exploiting a side effect to treat an uncommon symptom in cancer patients. Support Care Cancer 13, (2005)559–561.PubMedCrossRefGoogle Scholar
  66. Tscheng D.Z. Sialorrhea – Therapeutic drug options. Ann. Pharmacother. 36, (2002)1785–1790.PubMedCrossRefGoogle Scholar
  67. Uppal H.S., R. De, A.R. D’Souza, K. Pearman en D.W. Proops. Bilateral submandibular duct relocation for drooling: an evaluation of results for the Birmingham children’s hospital. Eur. Archs Otorhinolaryngol. 260, (2003)48–51.Google Scholar
  68. Watanabe S. en C. Dawes. Salivary flow rates and salivary film thickness in five-year-old children. J. Dent. Res. 69, (1990)1150–1153.PubMedCrossRefGoogle Scholar
  69. Webb K., D.S. Reddihough, H. Johnson, C.S. Bennett en T. Byrt. Long-term outcome of saliva-control surgery. Dev. Med. Child Neurol. 37, (1995)755–762.PubMedCrossRefGoogle Scholar
  70. Wilson S.W. en H.P. Henderson. The surgical treatment of drooling in Leicester: 12 years experience. Br. J. Plast. Surg. 52, (1999)335–338.PubMedCrossRefGoogle Scholar
  71. Wolff A., D. Harell, N. Gadoth en E. Mass. Submandibular and sublingual salivary gland function in familial dysautonomia. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodont. 94, (2002)315–319.CrossRefGoogle Scholar
  72. Wolff A., S. Ofer,M. Raviv,M. Helft en H.S. Cardash. The flow rate of whole and submandibular/sublingual gland saliva in patients receiving replacement complete dentures. J. Oral Rehabil. 31, (2004)340–343.PubMedCrossRefGoogle Scholar
  73. Wolff M.S. en I. Kleinberg. The effect of ammonium glycopyrrolate (Robinul®)-induced xerostomia on oral mucosal wetness and flow of gingival crevicular fluid in humans. Archs Oral Biol. 44, (1999)97–102.CrossRefGoogle Scholar
  74. Wong V., J.G. Sun en W. Wong. Traditional chinese medicine (tongue acupuncture) in children with drooling problems. Pediatr. Neurol. 25, (2001)47–54.PubMedCrossRefGoogle Scholar

Copyright information

© Bohn Stafleu van Loghum, onderdeel van Springer Uitgeverij 2008

Authors and Affiliations

  1. 1.Sectie Orale BiochemieAcademisch Centrum Tandheelkunde Amsterdam (ACTA), Vrije Universiteit en Universiteit van AmsterdamAmsterdam

Personalised recommendations